أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - digoxin-specific antibody fragment f(ab) (ovine), quantity: 40 mg - injection, powder for - excipient ingredients: mannitol; sodium acetate - digoxin-specific antibody fragment f(ab) (ovine) digifab is indicated for the treatment of known (or strongly suspected) life-threatening digoxin toxicity associated with ventricular arrhythmias, progressive bradycardia, or second or third degree heart block not responsive to atropine, and where additional measures besides withdrawal of digoxin and correction of serum electrolyte abnormalities are considered necessary. consequences of multiple dosing with digifab have not been evaluated.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meningococcal polysaccharide group c, quantity: 5 microgram; meningococcal polysaccharide group y, quantity: 5 microgram; meningococcal polysaccharide group w135, quantity: 5 microgram; meningococcal polysaccharide group a, quantity: 5 microgram; tetanus toxoid, quantity: 44 microgram - injection, powder for - excipient ingredients: sucrose; trometamol hydrochloride - nimenrix is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal diseases caused by neisseria meningitidis groups a, c, w-135 and y.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

body concepts group pty ltd - camellia sinensis -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

body concepts group pty ltd - rhodiola rosea -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

body concepts group pty ltd - crocus sativus -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

body concepts group pty ltd - ascorbic acid,bacopa monnieri,magnesium amino acid chelate,zinc amino acid chelate -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

body concepts group pty ltd - curcuma longa,curcumin -